Immix Biopharma, Inc. (IMMX) income statement
IMMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.96−0.08 (-1.14%)
Close on Nov 20, 2026Market cap $497.91MP/E –Yield –
Immix Biopharma, Inc. financial ratios
See a number that looks wrong?